Family Video fundraiser hits half million dollar mark

Family Video, the company that only recently launched an extremely clever campaign to raise money for the Lymphoma Research Foundation called 'Round It Up' is announcing that they have reached the half million dollar mark in donations.

'Round It Up For Lymphoma' is a campaign launched by the US movie and game rentailer that gives its customers the opportunity to support cancer research by rounding up their purchases to the nearest dollar (or they can simply make a donation to the LRF), with 100 percent of all donations going directly to the LRF.

“We have witnessed a remarkable response from our customers,” said Family Video President Keith Hoogland. “We are raising both awareness and money. Some people don’t know that lymphoma is cancer and the disease has personally affected others. The money and time donated by our customers, employees and community members has been incredible!”

The campaign only began on March 15, so it is staggering to see how quickly it has reached $500,000. It will continue through April 1.

Source: PRWeb

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap